#ASCO14 - Poster: Phase 1b study of abiraterone acetate and docetaxel in patients with metastatic castration-resistant prostate cancer

CHICAGO, IL USA (UroToday.com) - Presented by Scott T. Tagawa,¹ Edwin M. Posadas,² Justine Bruce,³ Emerson A. Lim,⁴ Daniel P. Petrylak,⁵ Weimin Peng,⁶ Scott Maul,⁶ Johan W. Smit,⁷ NamPhuong Tran,⁶ and David M. Nanus¹ at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting - May 30 - June 3, 2014 - Chicago, Illinois USA

 Click HERE to listen to an interview with Scott T. Tagawa, MD, one of the authors of this study

¹Weill Cornell Medical College, New York, NY USA
²Cedars-Sinai Medical Center, Los Angeles, CA USA
³University of Wisconsin School of Medicine and Public Health, Madison, WI USA
⁴Columbia University Medical Center, New York, NY USA
⁵Yale Cancer Center, New Haven, CT USA
⁶Janssen Research & Development, Los Angeles, CA USA
⁷Janssen Research & Development, Beerse, Belgium